JP2014527826A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014527826A5 JP2014527826A5 JP2014531243A JP2014531243A JP2014527826A5 JP 2014527826 A5 JP2014527826 A5 JP 2014527826A5 JP 2014531243 A JP2014531243 A JP 2014531243A JP 2014531243 A JP2014531243 A JP 2014531243A JP 2014527826 A5 JP2014527826 A5 JP 2014527826A5
- Authority
- JP
- Japan
- Prior art keywords
- lab
- bifidobacteria
- ptcc
- trehalose
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000186000 Bifidobacterium Species 0.000 claims 26
- 108090000623 proteins and genes Proteins 0.000 claims 20
- 238000000034 method Methods 0.000 claims 9
- 241000894006 Bacteria Species 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 7
- 239000002778 food additive Substances 0.000 claims 7
- 235000013373 food additive Nutrition 0.000 claims 7
- 239000007858 starting material Substances 0.000 claims 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 6
- 229940079593 drug Drugs 0.000 claims 6
- 239000006041 probiotic Substances 0.000 claims 5
- 230000000529 probiotic effect Effects 0.000 claims 5
- 235000018291 probiotics Nutrition 0.000 claims 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 4
- 101000662918 Lactococcus lactis subsp. lactis (strain IL1403) Trehalose 6-phosphate phosphorylase Proteins 0.000 claims 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 4
- 239000008103 glucose Substances 0.000 claims 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 4
- 239000000463 material Substances 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- 108020003272 trehalose-phosphatase Proteins 0.000 claims 4
- 239000001963 growth medium Substances 0.000 claims 3
- 238000002156 mixing Methods 0.000 claims 3
- 101150089952 trePP gene Proteins 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 2
- 238000007710 freezing Methods 0.000 claims 2
- 230000008014 freezing Effects 0.000 claims 2
- 235000014655 lactic acid Nutrition 0.000 claims 2
- 239000004310 lactic acid Substances 0.000 claims 2
- 239000002609 medium Substances 0.000 claims 2
- 101150095512 otsB gene Proteins 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241000192125 Firmicutes Species 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 241000194036 Lactococcus Species 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000003833 bile salt Substances 0.000 claims 1
- 229940093761 bile salts Drugs 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 230000003204 osmotic effect Effects 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11182643 | 2011-09-23 | ||
| EP11182643.4 | 2011-09-23 | ||
| PCT/EP2012/068634 WO2013041673A1 (en) | 2011-09-23 | 2012-09-21 | Modified gram positive bacteria and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017195120A Division JP6669703B2 (ja) | 2011-09-23 | 2017-10-05 | 改変されたグラム陽性菌及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014527826A JP2014527826A (ja) | 2014-10-23 |
| JP2014527826A5 true JP2014527826A5 (https=) | 2015-12-03 |
| JP6329903B2 JP6329903B2 (ja) | 2018-05-23 |
Family
ID=47040665
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014531243A Active JP6329903B2 (ja) | 2011-09-23 | 2012-09-21 | 改変されたグラム陽性菌及びその使用 |
| JP2017195120A Expired - Fee Related JP6669703B2 (ja) | 2011-09-23 | 2017-10-05 | 改変されたグラム陽性菌及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017195120A Expired - Fee Related JP6669703B2 (ja) | 2011-09-23 | 2017-10-05 | 改変されたグラム陽性菌及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US9347036B2 (https=) |
| EP (2) | EP2758513B1 (https=) |
| JP (2) | JP6329903B2 (https=) |
| KR (1) | KR102028771B1 (https=) |
| CN (1) | CN103917639B (https=) |
| AU (2) | AU2012311479B2 (https=) |
| BR (1) | BR112014006883A8 (https=) |
| CA (2) | CA2848471C (https=) |
| DK (1) | DK2758513T3 (https=) |
| ES (1) | ES2676270T3 (https=) |
| HU (1) | HUE038336T2 (https=) |
| RU (1) | RU2653757C2 (https=) |
| WO (1) | WO2013041673A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE038336T2 (hu) | 2011-09-23 | 2018-10-29 | Intrexon Actobiotics Nv | Módosított gram-pozitív baktériumok és alkalmazásaik |
| JP6117212B2 (ja) * | 2011-09-23 | 2017-04-19 | イントレクソン・アクトバイオテイクス・エヌブイＩｎｔｒｅｘｏｎ Ａｃｔｏｂｉｏｔｉｃｓ ＮＶ | 改変されたグラム陽性菌及びその使用 |
| US10696974B2 (en) | 2014-12-23 | 2020-06-30 | Ilya Pharma Ab | Methods for wound healing |
| US10905727B2 (en) * | 2016-01-14 | 2021-02-02 | Intrexon Actobiotics N.V. | Compositions and methods for the treatment of type 1 diabetes |
| CN118813511A (zh) | 2016-09-02 | 2024-10-22 | 英特瑞克斯顿阿克图比奥帝克斯有限公司 | 稳定表达il-10和胰岛素的遗传修饰的细菌 |
| RU2021135949A (ru) | 2016-09-13 | 2022-04-14 | Интрексон Актобиотикс Н.В. | Мукоадгезивный микроорганизм |
| IT201600122724A1 (it) * | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
| JP2022512639A (ja) * | 2018-10-09 | 2022-02-07 | セカンド ゲノム インコーポレイテッド | 上皮バリア機能障害の治療に有効なタンパク質を送達するためのラクトコッカス・ラクティス発現系 |
| CN114854807B (zh) * | 2022-05-23 | 2024-05-17 | 中国科学院微生物研究所 | 一种生产海藻糖六磷酸的方法 |
| CN121204013A (zh) * | 2025-11-04 | 2025-12-26 | 大连理工大学 | 一种海藻糖-6-磷酸磷酸化酶及其突变体与应用 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9006400D0 (en) | 1990-03-22 | 1990-05-23 | Ciba Geigy Ag | Bacterial vectors |
| US6277969B1 (en) | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
| IT1270123B (it) | 1994-10-05 | 1997-04-28 | Dompe Spa | Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia |
| GB9521568D0 (en) | 1995-10-20 | 1995-12-20 | Lynxvale Ltd | Delivery of biologically active polypeptides |
| US6033376A (en) | 1998-09-30 | 2000-03-07 | Allergan Sales, Inc. | Wound shaper sleeve |
| DE69914932T2 (de) | 1998-10-20 | 2004-12-09 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. | Verwendung eines zytokine-produzierenden lactococcus stammes zur behandlung von kolitis |
| PT1739178E (pt) | 1999-07-05 | 2010-11-17 | Actogenix Nv | Libertação de péptidos trifólios |
| AT407730B (de) | 2000-01-14 | 2001-05-25 | Hoerbiger Hydraulik | Betätigungsanordnung für schwenkbare teile an fahrzeugen |
| GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| DK1383897T3 (da) | 2001-05-03 | 2006-10-30 | Vlaams Interuniv Inst Biotech | Selv-containing Lactococcus-stamme |
| AU2003298291A1 (en) | 2002-11-15 | 2004-06-15 | Universiteit Gent | Self-containing lactobacillus strain |
| DK1720974T4 (da) | 2004-02-24 | 2022-01-31 | Chr Hansen As | Frosset mælkesyrebakteriekultur af individuelle pellets |
| JP2007537741A (ja) | 2004-05-18 | 2007-12-27 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） | 自己収容性乳酸桿株 |
| US9200249B2 (en) * | 2004-08-20 | 2015-12-01 | Actogenix N.V. | Method to improve Lactococcus preservation |
| ES2626610T3 (es) | 2005-08-30 | 2017-07-25 | Intrexon Actobiotics Nv | Bacterias de ácido láctico productoras del anti-TNF alfa para el tratamiento de la enfermedad inflamatoria intestinal |
| ES2405552T3 (es) | 2005-11-29 | 2013-05-31 | Actogenix N.V. | Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos |
| EP2016178B1 (en) | 2006-05-02 | 2017-07-12 | Intrexon Actobiotics NV | Microbial intestinal delivery of obesity related peptides |
| CA2672229A1 (en) | 2006-12-14 | 2008-06-19 | Actogenix N.V. | Delivery of binding molecules to induce immunomodulation |
| AU2008204442B2 (en) | 2007-01-12 | 2013-03-14 | Intrexon Actobiotics Nv | Lactococcus promoters and uses thereof |
| WO2008090223A2 (en) | 2007-01-25 | 2008-07-31 | Actogenix N.V. | Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus |
| EP3181682B1 (en) | 2008-09-29 | 2021-04-21 | Intrexon Actobiotics NV | Reduced colonization of microbes at the mucosa |
| RU2393214C1 (ru) * | 2009-01-29 | 2010-06-27 | Общество с ограниченной ответственностью "ИнноПроб"(ООО"ИнноПроб") | Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus nkjc, штамм lactobacillus acidophilus jch, штамм lactobacillus acidophilus kaa |
| CA2760248C (en) | 2009-04-30 | 2019-05-28 | Actogenix Nv | Cryoprotectants for freeze drying of lactic acid bacteria |
| JP6117212B2 (ja) * | 2011-09-23 | 2017-04-19 | イントレクソン・アクトバイオテイクス・エヌブイＩｎｔｒｅｘｏｎ Ａｃｔｏｂｉｏｔｉｃｓ ＮＶ | 改変されたグラム陽性菌及びその使用 |
| HUE038336T2 (hu) * | 2011-09-23 | 2018-10-29 | Intrexon Actobiotics Nv | Módosított gram-pozitív baktériumok és alkalmazásaik |
-
2012
- 2012-09-21 HU HUE12773253A patent/HUE038336T2/hu unknown
- 2012-09-21 CN CN201280053876.1A patent/CN103917639B/zh not_active Expired - Fee Related
- 2012-09-21 AU AU2012311479A patent/AU2012311479B2/en not_active Ceased
- 2012-09-21 ES ES12773253.5T patent/ES2676270T3/es active Active
- 2012-09-21 DK DK12773253.5T patent/DK2758513T3/en active
- 2012-09-21 US US14/346,488 patent/US9347036B2/en active Active
- 2012-09-21 CA CA2848471A patent/CA2848471C/en active Active
- 2012-09-21 RU RU2014116230A patent/RU2653757C2/ru active
- 2012-09-21 CA CA3131722A patent/CA3131722A1/en not_active Abandoned
- 2012-09-21 KR KR1020147010661A patent/KR102028771B1/ko not_active Expired - Fee Related
- 2012-09-21 EP EP12773253.5A patent/EP2758513B1/en active Active
- 2012-09-21 WO PCT/EP2012/068634 patent/WO2013041673A1/en not_active Ceased
- 2012-09-21 BR BR112014006883A patent/BR112014006883A8/pt not_active Application Discontinuation
- 2012-09-21 EP EP18172371.9A patent/EP3382006B1/en active Active
- 2012-09-21 JP JP2014531243A patent/JP6329903B2/ja active Active
-
2016
- 2016-01-21 US US15/003,426 patent/US9982228B2/en active Active
-
2017
- 2017-10-05 JP JP2017195120A patent/JP6669703B2/ja not_active Expired - Fee Related
- 2017-11-29 AU AU2017268593A patent/AU2017268593B9/en not_active Ceased
-
2018
- 2018-04-23 US US15/959,705 patent/US10519418B2/en active Active
-
2019
- 2019-12-13 US US16/713,737 patent/US10793825B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014527826A5 (https=) | ||
| RU2014116230A (ru) | Модифицированные грамположительные бактерии и их применение | |
| Wang et al. | The roles of moonlighting proteins in bacteria | |
| Torp et al. | Optimizing oral delivery of next generation probiotics | |
| Quinto et al. | Probiotic lactic acid bacteria: a review | |
| CN103620021B (zh) | 新型组合物 | |
| Corcoran et al. | Life under stress: the probiotic stress response and how it may be manipulated | |
| JP5727611B2 (ja) | 生体物質用の乾燥貯蔵安定化組成物 | |
| CN103932186B (zh) | 一种长双歧杆菌微胶囊及其制备方法 | |
| KR101604633B1 (ko) | 유산균 배지 조성물 및 이를 이용한 유산균 분말의 제조 방법 | |
| JP2014526266A5 (https=) | ||
| CN108368474A (zh) | 没有或几乎没有糖的稳定的干组合物 | |
| US20170333493A1 (en) | Probiotic bacteria for the prevention and treatment of salmonella | |
| Upadrasta et al. | Improving the stress tolerance of probiotic cultures: recent trends and future directions | |
| US9458467B2 (en) | Modified gram positive bacteria and uses thereof | |
| Lim et al. | Changes in the viability of lactic acid bacteria during storage of freeze-dried yogurt snacks | |
| Ouled-Haddar et al. | Lactobacillus plantarum G1 microencapsulation enhanced its viability during storage and gastrointestinal transit | |
| Do Carmo et al. | Applications of probiotic bacteria and dairy foods in health | |
| Argañaraz-Martínez et al. | Probiotic applications of bifidobacteria in poultry: administration methods and microencapsulation techniques | |
| CN103525704A (zh) | 一种提高乳酸菌冻干存活率的方法 | |
| KR102878796B1 (ko) | 칼슘-알긴산 비드로 포집된 유산균의 제조 방법 | |
| Lee et al. | Optimal production of fermented whey presenting bifidogenic growth stimulator activity | |
| Denkova et al. | Highly active probiotic concentrates with long shelf life obtained using cryoprotectants of plant origin | |
| Seveline | Viability and Survival of Lactobacillus casei Encapsulated with Whey, Sucrose and Maltodextrin Using Freeze-Dried Technique | |
| Ruiz et al. | Improving Probiotics for Functional Foods |